The primary symptoms of mullerian adenoarcinoma are abdominal pain and bleeding, unusual vaginal secretions, an enlarged uterus and a pelvic mass. Additional signs of this relatively rare cancer include irregular or no menstruation in pre-menopausal women, post-menopausal bleeding, fatigue and painful urination, according to RightDiagnosis.com.
Mullerian adenocarcinoma is a very rare and aggressive form of uterine cancer. The mullerian ducts in females differentiate during gestation to become reproductive organs, so this cancer can develop in the ovaries and fallopian tubes as well, a National Institutes for Health article explains.
The most frequent treatment for mullerian adenocarcinoma is a hysterectomy. However, due to a high risk for recurrence, surgeons may opt to also perform a lymphadenectomy in the effort to eliminate as much of the malignancy as possible. To date, no evidence supports the efficacy of chemotherapy in preventing recurrence, an article published by Hindawi reports.
The percentage of women over age 55 who develop mullerian adenocarcinoma is between 1.8 and 4.3. The average age of women with the condition is 62. Post-menopausal women who are overweight and childless run a greater risk of developing this type of cancer. Also, those who have taken tamoxifen for breast cancer or infertility are somewhat more susceptible to this disease, as reported by Hindawi.